Synthesis and Characterization of a New Series of Bis(allylic-α-aminophosphonates) under Mild Reaction Conditions
Abstract
:1. Introduction
2. Results and Discussion
3. Materials and Methods
3.1. Chemistry
3.1.1. General Procedure and Spectral Data for the Multicomponent Kabachnik–Fields Reaction for the Preparation of Bis(α-aminophosphonates) 4
- Tetraethyl [(ethane-1,2-diylbis(azanediyl))bis(phenylmethylene)]bis(phosphonate) (4a), (1.41 g, 55%) was obtained as a white solid following the general procedure (method A). The title compound 4a (1.54 g, 60%) was obtained as white solid as described in the general procedure (method B). Data for 4a: mp 97–98 °C. 1H NMR (400 MHz, CDCl3) δ 7.36–7.19 (m, 8H, Ar-CH), 4.09–3.69 (m, 10H, H2C-O and P-CH), 2.84–2.53 (m, 6H, CH2 and NH), 1.20 (t, 6H, 3JHH = 7.0 Hz, CH3), 1.06 (t, 6H, 3JHH = 7.1 Hz, CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 23.3 ppm.
- Tetraethyl [(ethane-1,2-diylbis(azanediyl))bis(p-tolylmethylene)]bis(phosphonate) (4b), (1.92 g, 71%) was obtained as a viscous oil following the general procedure (method A). The title compound 4b (1.54 g, 57%) was obtained as viscous oil as described in the general procedure (method B). Data for 4b: 1H NMR (400 MHz, CDCl3) δ 7.26–7.22 (m, 4H, Ar-CH), 7.14–7.09 (m, 4H, Ar-CH), 4.13–3.78 (m, 10H, H2C-O and P-CH), 2.63–2.46 (m, 4H, CH2), 2.32 (s, 6H, CH3), 2.17 (bs, 2H, NH), 1.29–1.12 (m, 12H, CH3) ppm. 13C {1H} NMR (101 MHz, CDCl3) δ 137.5 (Ar-C), 132.8 (Ar-C), 129.1 (Ar-CH), 128.4 (Ar-CH), 62.9 (P-OCH2), 60.4 (d, 1JPC = 154.7 Hz, P-CH), 47.0 (CH2), 37.4 (CH2), 21.2 (CH3), 16.3 (CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 23.7 ppm.
- Tetraethyl [(propane-1,3-diylbis(azanediyl))bis(phenylmethylene]bis(phosphonate) (4c), (1.82 g, 69%) was isolated as a viscous clear oil using the general procedure (method A). The title compound 4c (1.95 g, 74%) was produced as a viscous clear oil as described in the general procedure (method B). Data for 4c: 1H NMR (400 MHz, CDCl3) δ 7.42–7.13 (m, 8H, Ar-CH), 4.12–3.62 (m, 10H, H2C-O and P-CH), 2.63–2.33 (m, 4H, CH2), 2.20 (bs, 2H, NH), 1.69–1.46 (m, 2H, CH2), 1.33–0.95 (m, 12H, CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 23.4 ppm.
- Tetraethyl [(propane-1,3-diylbis(azanediyl))bis(p-tolylmethylene]bis(phosphonate) (4d), (2.41 g, 87%) was isolated as a viscous oil using the general procedure (method A). The title compound 4d (2.19 g, 79%) was produced as a viscous oil as described in the general procedure (method B). Data for 4d: 1H NMR (400 MHz, CDCl3) δ 7.18 (d, 3JHH = 7.2 Hz, 4H, Ar-CH), 7.06 (d, 3JHH = 7.6 Hz, 4H, Ar-CH), 4.02–3.69 (m, 10H, H2C-O and P-CH), 2.55–2.37 (m, 4H, CH2), 2.26 (s, 6H, CH3), 2.09 (bs, 2H, NH), 1.57–1.45 (m, 2H, CH2), 1.18 (t, 6H, 3JHH = 7.1 Hz, CH3), 1.06 (t, 6H, 3JHH = 7.1 Hz, CH3) ppm. 13C {1H} NMR (101 MHz, CDCl3) δ 137.1 (Ar-C), 131.7 (Ar-C), 128.6 (Ar-CH), 128.0 (Ar-CH), 62.3 (P-OCH2), 59.9 (d, 1JPC = 153.1 Hz, P-CH), 45.5 (d, 3JPC = 15.2 Hz, CH2), 28.5 (CH2), 20.6 (CH3), 15.8 (d, 3JPC = 17.2 Hz, CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 23.6 ppm.
- Tetraethyl [(propane-1,3-diylbis(azanediyl))bis((4-methoxyphenyl)methylene)]bis(phosphonate) (4e), (1.93 g, 66%) was isolated as a viscous clear oil as described in the general procedure (method A). The title compound 4e (1.85 g, 63%) was obtained as a viscous clear oil as described in the general procedure (method B). Data for 4e: 1H NMR (400 MHz, CDCl3) δ 7.25 (d, 3JHH = 7.9 Hz, 4H, Ar-CH), 6.83 (d, 3JHH = 8.5 Hz, 4H, Ar-CH), 4.35 (bs, 2H, NH), 4.03–3.88 (m, 10H, H2C-O and P-CH), 3.75 (s, 6H, CH3), 2.54–2.39 (m, 4H, CH2), 1.60–1.52 (m, 2H, CH2), 1.22 (t, 6H, 3JHH = 7.0 Hz, CH3), 1.09 (t, 6H, 3JHH = 7.0 Hz, CH3) ppm 31P NMR (162 MHz, CDCl3) δ 23.7 ppm.
- Tetraethyl [(propane-1,3-diylbis(azanediyl))bis((4-chlorophenyl)methylene)]bis(phosphonate) (4f), (2.02 g, 68%) was isolated as a viscous oil as described in the general procedure (method A). The title compound 4f (2.11 g, 71%) was obtained as viscous oil as described in the general procedure (method B). Data for 4f: 1H NMR (400 MHz, CDCl3) δ 7.22–7.07 (m, 8H, Ar-CH), 3.93–3.64 (m, 10H, H2C-O and P-CH), 2.45–2.24 (m, 4H, CH2), 1.76 (bs, 2H, NH), 1.46–1.37 (m, 2H, CH2), 1.09–0.95 (m, 12H, CH3) ppm. 13C {1H} NMR (101 MHz, CDCl3) δ 134.3 (Ar-C), 132.8 (Ar-C), 129.2 (d, 3JPC = 6.0 Hz,Ar-CH), 127.9 (Ar-CH), 62.3 (P-OCH2), 60.0 (d, 1JPC = 152.8 Hz, P-C), 45.4 (d, 3JPC = 16.6 Hz,CH2), 29.3 (CH2), 15.7 (CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 22.6 ppm.
- Tetraethyl [(propane-1,3-diylbis(azanediyl))bis((4-fluorophenyl)methylene)]bis(phosphonate) (4g), (1.69 g, 60%) was obtained as a viscous oil following the general procedure (method A). The title compound 4g (1.63 g, 58%) was obtained as a viscous oil using the general procedure (method B). Data for 4g: 1H NMR (400 MHz, CDCl3) δ 7.28–6.94 (m, 4H, Ar-CH), 6.71–6.50 (m, 4H, Ar-CH), 3.93–3.44 (m, 10H, H2C-O and P-CH), 2.33–2.05 (m, 4H, CH2), 1.71–1.63 (m, 2H, NH), 1.37–1.23 (m, 2H, CH2), 1.03–0.70 (m, 12H, CH3) ppm. 13C {1H} NMR (101 MHz, CDCl3) δ 161.5 (d, 1JCF = 245.8 Hz, C-F), 131.3 (Ar-C), 129.2 (Ar-CH), 114.3 (d, 3JPC = 21.6 Hz, Ar-CH), 61.8 (P-OCH2), 59.6 (d, 1JPC = 153.3 Hz, P-CH), 45.1 (d, 3JPC = 17.3 Hz, CH2), 29.0 (CH2), 15.4 (d, 3JPC = 15.8 Hz, CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 22.9 ppm. 19F NMR (376 MHz, CDCl3) δ –115.0 ppm.
- Tetraethyl [(propane-1,3-diylbis(azanediyl))bis(ethane-1,1-diyl)]bis(phosphonate) (4h), (1.59 g, 79%) was isolated as a viscous oil as described in the general procedure (method A). The title compound 4h (1.73 g, 86%) was obtained as a viscous oil as described in the general procedure (method B). Data for 4h: 1H NMR (400 MHz, CDCl3) δ 4.19–4.08 (m, 10H, H2C-O and P-CH), 3.00–2.91 (m, 2H, CH2), 2.84–2.67 (m, 4H, CH2), 1.48 (bs, 2H, NH), 1.34–1.25 (m, 18H, CH3). 13C {1H} NMR (101 MHz, CDCl3) 62.0 (P-OCH2), 50.5 (d, 1JPC = 153.9 Hz, P-CH), 46.1 (d, 3JPC = 11.0 Hz, CH2), 30.6 (CH2), 16.5 (d, 3JPC = 5.53 Hz,CH3), 15.2 (CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 28.6 ppm.
3.1.2. General Procedure and Spectral Data for the Nucleophilic Substitution of Bis(α-aminophosphonates) 4 with Ethyl (2-Bromomethyl)acrylate 5 for the Synthesis of Bis(allylic-α-aminophosphonates) 6
- Diethyl 2,2′-[(ethane-1,2-diylbis(((diethoxyphosphoryl)(phenyl)methyl)azanediyl))bis(methylene)]diacrylate (6a), (0.36 g, 69%) was isolated as a white solid as described in the general procedure. Data for 6a: mp 150–151 °C. 1H NMR (300 MHz, CDCl3) δ 7.56–7.33 (m, 10H, Ar-CH), 6.24 (s, 2H, H2C=), 5.86 (s, 2H, H2C=), 4.21–4.08 (m, m, 10H, H2CO-P and HC-P), 3.92–3.86 (m, 2H, H2CO-C), 3.76–3.66 (m, 2H, H2CO-C and H2C-N), 3.35–3.30 (m, 2H, H2C-N), 3.21–3.17 (m, 2H, H2C-N), 2.50–2.37 (m, 2H, CH2), 1.28–1.22 (m, 12H, CH3), 0.98 (t, 3JHH = 7.2 Hz, 6H, CH3) ppm. 13C {1H} NMR (101 MHz, CDCl3) δ 166.7 (C=O), 138.6 (C=CH2), 132.4 (d, 2JPC = 5.8 Hz Ar-C), 130.8 (d, 3JPC = 8.7 Hz Ar-CH), 128.1 (Ar-CH), 127.9 (Ar-CH), 125.9 (H2C=), 62.4 (P-OCH2), 61.4 (d, 1JPC = 162.8 Hz, P-CH), 60.4 (C-OCH2), 52.7 (d, 3JPC = 10.3 Hz, N-CH2), 50.5 (d, 3JPC = 5.8 Hz, N-CH2), 31.6 (CH2), 29.0 (CH2), 16.4 (d, 3JPC = 5.8 Hz, CH3), 14.1 (CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 23.1 ppm. ESI-HRMS (CI) m/z calcd for C36H55N2O10P2 ([M + H]+) 737.3332, found 737.3334.
- Diethyl 2,2′-[(ethane-1,2-diylbis(((diethoxyphosphoryl)(p-tolyl)methyl)azanediyl))bis(methylene)]diacrylate (6b), (0.46 g, 85%) was isolated as a viscous oil as described in the general procedure. Data for 6b: 1H NMR (400 MHz, CDCl3) δ 7.32 (d, 3JHH = 7.7 Hz, 4H, Ar-CH), 7.13 (d, 3JHH = 8.0 Hz, 4H, Ar-CH), 6.28 (s, 2H, H2C=), 5.93 (s, 2H, H2C=), 4.22–4.01 (m, 10H, H2CO-P and HC-P), 3.97–3.87 (m, 2H, H2CO-C), 3.80–3.66 (m, 4H, H2CO-C and H2C-N), 3.27–3.24 (m, 2H, H2C-N), 3.19–3.14 (m, 2H, CH2), 2.55–2.49 (m, 2H, CH2), 2.35 (s, 6H, CH3), 1.33 (t, 6H, 3JHH = 7.2 Hz, CH3), 1.26 (t, 6H, 3JHH = 7.2 Hz, CH3), 1.05 (t, 3JHH = 7.1 Hz, 6H, CH3) ppm. 13C {1H} NMR (101 MHz, CDCl3) δ 166.9 (C=O), 138.5 (C=CH2), 137.5 (Ar-C), 130.5 (Ar-CH), 130.4 (Ar-CH), 128.9 (Ar-C), 126.0 (H2C=), 62.5 (P-OCH2), 61.7 (d, 1JPC = 151.6 Hz, P-CH), 60.5 (C-OCH2), 52.5 (N-CH2), 50.6 (N-CH2), 21.1 (CH3), 16.6 (d, 3JPC = 5.6 Hz, CH3), 16.2 (d, 3JPC = 5.8 Hz, CH3), 14.2 (CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 23.7 ppm. ESI-HRMS (CI) m/z calcd for C38H59N2O10P2 ([M + H]+) 765.3645, found 765.3638.
- Diethyl 2,2′-[(propane-1,3-diylbis(((diethoxyphosphoryl)(phenyl)methyl)azanediyl))bis(methylene)]diacrylate (6c), (0.39 g, 74%) obtained as a viscous clear oil as described in the general procedure. Data for 6c: 1H NMR (300 MHz, CDCl3) δ 7.39–7.18 (m, 10H, Ar-CH), 6.11 (s, 2H, H2C=), 5.68 (s, 2H, H2C=), 4.20–3.67 (m, 14H, H2CO-P, H2CO-C, HC-P), 3.16 (s, 4H, H2C-N), 2.50–2.32 (m, 4H, H2C-N), 1.61–1.52 (m, 2H, CH2), 1.27–1.14 (m, 12H, CH3), 1.06 (t, 3JHH = 7.3 Hz, 6H, CH3) ppm. 13C {1H} NMR (75 MHz, CDCl3) δ 165.8 (C=O), 137.3 (C=CH2), 135.0 (Ar-C), 127.4 (Ar-CH), 127.3 (Ar-CH), 126.7 (Ar-CH), 124.6 (C=CH2), 61.8 (P-OCH2), 60.1 (d, 1JPC = 153.1 Hz, CH-P), 59.5 (C-OCH2), 53.5 (N-CH2), 51.1 (CH2), 45.0 (CH2), 28.6 (CH2), 15.2 (CH3), 13.1 (CH3) ppm. 31P NMR (121 MHz, CDCl3) δ 23.6 ppm. ESI-HRMS (CI) m/z calcd for C37H56N2O10P2 ([M + H]+) 751.3488, found 751.3494.
- Diethyl 2,2′-[(propane-1,3-diylbis(((diethoxyphosphoryl)(p-tolyl)methyl)azanediyl))bis(methylene)]diacrylate (6d), (0.39 g, 71%) was isolated as a viscous clear oil as described in the general procedure. Data for 6d: 1H NMR (300 MHz, CDCl3) δ 7.37–7.00 (m, 8H, Ar-CH), 6.21 (s, 2H, H2C=), 5.89 (s, 2H, H2C=), 4.19–3.56 (m, 12H, H2CO-P, HC-P and H2CO-C), 3.72–3.56 (m, 4H, H2CO-C and H2C-N), 3.20–3.03 (m, 2H, H2C-N), 2.98–2.87 (m, 2H, CH2), 2.26 (s, 6H, CH3), 1.74–1.51 (m, 2H, CH2), 1.29–1.14 (m, 12H, CH3), 0.98–0.92 (m, 6H, CH3) ppm. 13C {1H} NMR (101 MHz, CDCl3) δ 166.7 (C=O), 138.3 (C=CH2), 137.3 (Ar-C), 130.3 (d, 2JPC = 8.6 Hz, Ar-C), 129.4 (d, 3JPC = 6.0 Hz, Ar-CH), 128.6 (Ar-CH), 125.7 (C=CH2), 62.0 (d, 2JPC = 7.1 Hz, P-OCH2), 61.9 (d, 2JPC = 7.0 Hz, P-OCH2), 61.2 (d, 1JPC = 138.7 Hz, P-CH), 60.2 (C-OCH2), 51.7 (N-CH2), 49.6 (N-CH2), 26.8 (CH2), 20.9 (CH3), 16.3 (d, 3JPC = 5.9 Hz, CH3), 16.0 (d, 3JPC = 5.6 Hz, CH3), 14.0 (CH3) ppm. 31P NMR (121 MHz, CDCl3) δ 23.7 ppm. ESI-HRMS (CI) m/z calcd for C39H61N2O10P2 ([M + H]+) 779.3801, found 779.3810.
- Diethyl 2,2′-[(propane-1,3-diylbis(((diethoxyphosphoryl)(4-methoxyphenyl)methyl)azanediyl))bis(methylene)]diacrylate (6e), (0.42 g, 74%) was isolated as a viscous clear oil as described in the general procedure. Data for 6e: 1H NMR (400 MHz, CDCl3) δ 7.39–7.36 (m, 4H, Ar-CH), 6.88–6.85 (m, 4H, Ar-CH), 6.29 (s, 2H, H2C=), 5.95 (s, 2H, H2C=), 4.20–3.86 (m, 12H, H2CO-P, HC-P and H2CO-C), 3.81 (s, 6H, OCH3), 3.75–3.67 (m, 4H, H2CO-C and H2C-N), 3.20–3.13 (m, 2H, H2C-N), 3.04–2.94 (m, 2H, CH2), 2.42–2.27 (m, 2H, CH2), 1.71–1.62 (m, 2H, CH2), 1.31–1.25 (m, 12H, CH3), 0.96 (t, 3JHH = 7.1, 3H, CH3), 0.94 (t, 3JHH = 7.1, 3H, CH3) ppm. 13C {1H} NMR (101 MHz, CDCl3) δ 166.9 (C=O), 159.2 (Ar-C), 138.5 (C=CH2), 131.9 (Ar-C), 125.9 (=CH2), 124.7 (d, 3JPC = 5.9 Hz, Ar-CH), 124.5 (d, 3JPC = 5.9 Hz, Ar-CH), 113.5 (Ar-CH), 62.2 (d, 2JPC = 7.3Hz, P-OCH2), 62.1 (d, 2JPC = 7.3 Hz, P-OCH2), 61.1 (d, 1JPC = 161.2 Hz, P-CH), 60.5 (C-OCH2), 55.1 (N-CH2), 51.7 (N-CH2), 49.8 (CH2), 27.0 (CH3), 16.5 (d, 3JPC = 5.8 Hz, CH3), 16.2 (d, 3JPC = 5.8 Hz, CH3), 14.2 (CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 23.7 ppm. ESI-HRMS (CI) m/z calcd for C39H61N2O12P2 ([M + H]+) 811.3700, found 811.3697.
- Diethyl 2,2′-[(propane-1,3-diylbis(((4-chlorophenyl)(diethoxyphosphoryl)methyl)azanediyl))bis(methylene)]diacrylate (6f), (0.50 g, 87%) obtained as a viscous clear oil as described in the general procedure. Data for 6f: 1H NMR (300 MHz, CDCl3) δ 7.39–7.11 (m, 8H, Ar-CH), 6.21 (s, 2H, H2C=), 5.79 (s, 2H, H2C=), 4.25–3.51 (m, 16H, H2CO-P, HC-P, H2CO-C, and H2C-N), 3.24–2.70 (m, 4H, H2C-N), 2.34–2.14 (m, 2H, CH2), 1.76–1.44 (m, 2H, CH2), 1.23–0.76 (m, 18H, CH3) ppm. 13C {1H} NMR (75 MHz, CDCl3) δ 166.6 (C=O), 138.4 (C=CH2), 133.8 (Ar-C), 131.7 (Ar-CH), 128.2 (Ar-CH), 125.9 (=CH2), 124.6 (Ar-C), 62.2 (P-OCH2), 60.8 (d, 1JPC = 143.7 Hz, P-CH), 60.4 (C-OCH2), 51.9 (N-CH2), 49.7 (N-CH2), 26.9 (CH2), 16.3 (CH3), 14.0 (CH3) ppm. 31P NMR (121 MHz, CDCl3) δ 23.00 ppm. ESI-HRMS (CI) m/z calcd for C37H55Cl2N2O10P2 ([M + H]+) 819.2709, found 819.2714.
- Diethyl 2,2′-[(propane-1,3-diylbis(((diethoxyphosphoryl)(4-fluorophenyl)methyl)azanediyl))bis(methylene)]diacrylate (6g), (0.41 g, 75%) was isolated as a viscous clear oil as described in the general procedure. Data for 6g: 1H NMR (400 MHz, CDCl3) δ 7.45–7.41 (m, 4H, Ar-CH), 7.06–7.00 (m, 4H, Ar-CH), 6.28 (s, 2H, H2C=), 5.93 (s, 2H, H2C=), 4.22–4.07 (m, 10H, H2CO-P and HC-P), 3.97–3.87 (m, 2H, H2CO-C), 3.81–3.68 (m, 4H, H2CO-C and H2C-N), 3.23–3.18 (m, 2H, H2C-N), 3.05–2.98 (m, 2H, CH2), 2.35–2.29 (m, 2H, CH2), 1.68–1.60 (m, 2H, CH2), 1.33–1.26 (m, 12H, CH3), 1.06 (t, 6H, 3JHH = 7.3 Hz, CH3) ppm. 13C {1H} NMR (101 MHz, CDCl3) δ 166.7 (C=O), 162.4 (d, 1JCF = 245.9 Hz, C-F), 138.4 (C=CH2), 132.2 (Ar-CH), 128.9 (Ar-C), 126.0 (C=CH2), 115.2 (d, 3JPC = 21.1 Hz, Ar-CH), 62.2 (d, 2JPC = 20.9 Hz, P-OCH2), 61.0 (d, 1JPC = 159.4 Hz, P-C), 60.5 (C-OCH2), 51.8 (N-CH2), 49.7 (N-CH2), 27.0 (CH2), 16.5 (CH3), 16.2 (CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 23.4 ppm. 19F NMR (376 MHz, CDCl3) δ −114.2 ppm. ESI-HRMS (CI) m/z calcd for C37H55F2N2O10P2 ([M + H]+) 787.3300, found 787.3295.
- Diethyl 2,2′-[(propane-1,3-diylbis((1-(diethoxyphosphoryl)ethyl)azanediyl))bis(methylene)]diacrylate (6h), (0.30 g, 69%) was isolated as a viscous clear oil as described in the general procedure. Data for 6h: 1H NMR (400 MHz, CDCl3) δ 6.13 (s, 2H, H2C=), 5.77 (s, 2H, H2C=), 4.14–3.95 (m, 12H, H2CO-P, HC-P and H2CO-C), 3.50–3.26 (m, 4H, H2CO-C and H2C-N), 3.07–2.99 (m, 2H, H2C-N), 2.52–2.41 (m, 2H, CH2), 1.49–1.45 (m, 2H, CH2), 1.25–1.13 (m, 24H, CH3) ppm. 13C {1H} NMR (101 MHz, CDCl3) δ 166.7 (C=O), 139.0 (C=CH2), 125.3 (=CH2), 61.0 (d, 2JPC = 7.2 Hz, P-OCH2), 60.3 (C-OCH2), 52.0 (N-CH2), 51.4 (d, 1JPC = 141.6 Hz, P-CH), 49.2 (N-CH2), 28.1 (CH2), 16.4 (CH3), 14.0 (CH3), 11.2 (d, 3JCP = 4.7 Hz, CH3), 10.7 (d, 3JCP = 4.8 Hz, CH3) ppm. 31P NMR (162 MHz, CDCl3) δ 28. 5 ppm. ESI-HRMS (CI) m/z calcd for C27H53N4O10P2 ([M + H]+) 627.3175, found, 627.3175.
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Sample Availability
References
- Tal, N.; Rudnick-Glick, S.; Margel, S. Novel bisphosphonates near infrared fluorescent and non-fluorescent nanoparticles of narrow size distribution for bone targeting. Polymer 2017, 132, 188–192. [Google Scholar] [CrossRef]
- Paredes, L.; Gonçalves, L.S.; Menezes Aguiar Miranda, A.M.; de Noronha Santos Netto, J.; da Cruz Perez, D.E.; Ramôa Pires, F. Knowledge of dental professionals and dental students on bisphosphonates and bisphosphonate-associated osteonecrosis of the jaws. Res. Soc. Dev. 2022, 11, e16211931553. [Google Scholar] [CrossRef]
- Fuggle, N.; Al-Daghri, N.; Bock, O.; Branco, J.; Bruyere, O.; Casado, E.; Cavalier, E.; Cortet, B.; de Wit, M.; Giusti, A.; et al. Novel formulations of oral bisphosphonates in the treatment of osteoporosis. Aging Clin. Exp. Res. 2022, 34, 2625–2634. [Google Scholar] [CrossRef] [PubMed]
- Fu, X.; Yu, X.; Jiang, J.; Yang, J.; Chen, L.; Yang, Z.; Yu, C. Small molecule-assisted assembly of multifunctional ceria nanozymes for synergistic treatment of atherosclerosis. Nat. Commun. 2022, 13, 6528. [Google Scholar] [CrossRef] [PubMed]
- Fields, S.C. Synthesis of natural products containing a C–P bond. Tetrahedron 1999, 55, 12237–12273. [Google Scholar] [CrossRef]
- Mucha, A.; Kafarski, P.; Berlicki, L. Remarkable potential of the α-aminophosphonate/phosphinate structural motif in Medicinal Chemistry. J. Med. Chem. 2011, 54, 5955–5980. [Google Scholar] [CrossRef]
- Hiratake, J.; Oda, J. Aminophosphonic and aminoboronic acids as key elements of a transition state analogue inhibitor of enzymes. Biosci. Biotech. Biochem. 1997, 61, 211–218. [Google Scholar] [CrossRef] [Green Version]
- Lavielle, G.; Hautefaye, P.; Schaeffer, C.; Boutin, J.A.; Cudennec, C.A.; Pierre, A. New alpha-amino phosphonic acid derivatives of vinblastine: Chemistry and antitumor activity. J. Med. Chem. 1991, 34, 1998–2003. [Google Scholar] [CrossRef]
- Bhattacharya, A.K.; Raut, D.S.; Rana, K.C.; Polanki, I.K.; Khan, M.S.; Iram, S. Diversity-oriented synthesis of α-aminophosphonates: A new class of potential anticancer agents. Eur. J. Med. Chem. 2013, 66, 146–152. [Google Scholar] [CrossRef]
- Bhattacharya, A.K.; Rana, K.C.; Pannecouque, C.; De Clercq, E. An efficient synthesis of a hydroxyethylamine (HEA) isostere and its α-aminophosphonate and phosphoramidate derivatives as potential anti-HIV agents. ChemMedChem 2012, 7, 1601–1611. [Google Scholar] [CrossRef]
- Lejczak, B.; Kafarski, P.; Sztajer, H.; Mastalerz, P. Antibacterial activity of phosphono dipeptides related to alafosfalin. J. Med. Chem. 1986, 29, 2212–2217. [Google Scholar] [CrossRef] [PubMed]
- Maier, L.; Diel, P.J. Organic phosphorus compounds 94. Preparation, physical and biological properties of amino-arylmethylphosphonic- and –phosphonous acids. Phosphorus Sulfur Silicon Relat. Elem. 1991, 57, 57–64. [Google Scholar] [CrossRef]
- Kafarski, P.; Lejczak, B. Biological activity of aminophosphonic acids. Phosphorus Sulfur Silicon Relat. Elem. 1991, 63, 193–215. [Google Scholar] [CrossRef]
- Panwar, P.; Singh, S.; Kumar, N.; Rawat, H.; Mishra, A.K. Synthesis, characterization, and in vivo skeletal localization of a new 99mTc-based multidentate phosphonate chelate: 5-amino-1,3-bis(ethylamine-(N,N-dimethyl diphosphonic acid) acetamido) benzene. Bioorg. Med. Chem. 2007, 15, 1138–1145. [Google Scholar] [CrossRef]
- Cherkasov, R.A.; Garifzyanov, A.R.; Zakharov, S.V.; Vinokurov, A.V.; Galkin, V.I. Liquid extraction of noble metal ions with bis(α-aminophosphonates). Russ. J. Gen. Chem. 2006, 76, 417–420. [Google Scholar] [CrossRef]
- Garifzyanov, A.R.; Zakharoov, S.V.; Kryukov, S.V.; Galkin, V.I.; Cherkasov, R.A. Liquid extraction of noble metal ions with an α-amino phosphonate. Russ. J. Gen. Chem. 2005, 75, 1208–1211. [Google Scholar] [CrossRef]
- Jagodic, V.; Herak, M.J. Synthesis and physical properties of a novel aminophosphonic acid as an extracting agent for metals. J. Inorg. Nucl. Chem. 1970, 32, 1323–1332. [Google Scholar] [CrossRef]
- Bilgici, Z.S.; Ordu, O.D.; Isik, M.; Avci, D. Synthesis and polymerizations of six aminophosphonate-containing methacrylates. J. Polym. Sci. A Polym. Chem. 2011, 49, 5042–5048. [Google Scholar] [CrossRef]
- Zhang, Y.; Zhao, Y.; Yang, B.; Zhu, C.; Wei, Y.; Tao, L. ‘One pot’ synthesis of well-defined poly(aminophosphonate)s: Time for the Kabachnik-Fields reaction on the stage of polymer chemistry. Polym. Chem. 2014, 5, 1857–1862. [Google Scholar] [CrossRef]
- Rezaei, Z.; Firouzabadi, H.; Iranpoor, N.; Ghaderi, A.; Jafari, M.R.; Jafari, A.A.; Zare, H.R. Design and one-pot synthesis of α-aminophosphonates and bis(α-aminophosphonates) by iron(III) chloride and cytotoxic activity. Eur. J. Med. Chem. 2009, 44, 4266–4275. [Google Scholar] [CrossRef]
- Nag, S.; Batra, S. Applications of allylamines for the syntheses of aza-heterocycles. Tetrahedron 2011, 67, 8959–9061. [Google Scholar] [CrossRef]
- William, A.D.; Lee, A.C.-H.; Goh, K.C.; Blanchard, S.; Poulsen, A.; Teo, E.L.; Nagaraj, H.; Lee, C.P.; Wang, H.; Williams, M.; et al. Discovery of kinase spectrum selective macrocycle (16E)-14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a potent inhibitor of cyclin dependent kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3) for the treatment of cancer. J. Med. Chem. 2012, 55, 169–196. [Google Scholar] [CrossRef]
- Skoda, E.M.; Davis, G.C.; Wipf, P. Allylic amines as key building blocks in the synthesis of (E)-alkene peptide isosteres. Org. Process Res. Dev. 2012, 16, 26–34. [Google Scholar] [CrossRef] [Green Version]
- Zhu, J.; Wang, Q.; Wang, M.-X. (Eds.) Multicomponent Reactions in Organic Synthesis; Wiley-VCH: Weinheim, Germany, 2015; ISBN 978-3-527-67820-4. [Google Scholar]
- Wang, Y.; Cobo, A.A.; Franz, A.K. Recent advances in organocatalytic asymmetric multicomponent cascade reactions for enantioselective synthesis of spirooxindoles. Org. Chem. Front. 2021, 8, 4315–4348. [Google Scholar] [CrossRef]
- Lemos, B.C.; Venturini Filho, E.; Fiorot, R.G.; Medici, F.; Greco, S.J.; Benaglia, M. Enantioselective Povarov reactions: An update of a powerful catalytic synthetic methodology. Eur. J. Org. Chem. 2022, 2022, e202101171. [Google Scholar] [CrossRef]
- Fouad, M.A.; Abdel-Hamid, H.; Ayoup, M.S. Two decades of recent advances of Ugi reactions: Synthetic and pharmaceutical applications. RSC Adv. 2020, 10, 42644–42681. [Google Scholar] [CrossRef] [PubMed]
- Knapp, J.M.; Kurth, M.J.; Shaw, J.T.; Younai, A. Strategic Applications of Multicomponent Reactions in Diversity-Oriented Synthesis; Trabocchi, A., Ed.; Willey: New York, NY, USA, 2013; pp. 29–57. [Google Scholar] [CrossRef]
- Schreiber, S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 2000, 287, 1964–1969. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Varga, P.R.; Keglevich, G. Synthesis of α-aminophosphonates and related derivatives; the last decade of the Kabachnik-Fields reaction. Molecules 2021, 26, 2511. [Google Scholar] [CrossRef] [PubMed]
- Keglevich, G.; Balint, E. The Kabachnik–Fields reaction: Mechanism and synthetic use. Molecules 2012, 17, 12821–12835. [Google Scholar] [CrossRef] [Green Version]
- Mulla, S.A.R.; Pathan, M.Y.; Chavan, S.S.; Gample, S.P.; Sarkar, D. Highly efficient one-pot multi-component synthesis of α-aminophosphonates and bis-α-aminophosphonates catalyzed by heterogeneous reusable silica supported dodecatungstophosphoric acid (DTP/SiO2) at ambient temperature and their antitubercular evaluation against Mycobactrium Tuberculosis. RSC Adv. 2014, 4, 7666–7672. [Google Scholar] [CrossRef]
- Aissa, R.; Guezane-Lekoud, S.; Toffano, M.; Gali, L.; Aribi-Zouioueche, L. Fiaud’s acid, a novel organocatalyst for diastereoselective bis α-aminophosphonates synthesis with in-vitro biological evaluation of antifungal, antioxidant and enzymes inhibition potential. Bioorg. Med. Chem. Lett. 2021, 41, 128000. [Google Scholar] [CrossRef] [PubMed]
- Messaoudi, C.; Jmaï, M.; Jismy, B.; Abarbri, M.; M’rabet, H. An easy and regioselective synthesis of new functionalized isoxazoline derivatives via a 1,3-dipolar cycloaddition reaction. Synth. Commun. 2022, 52, 2291–2300. [Google Scholar] [CrossRef]
- Saroka, M.; Kaliniak, M.; Lecion, P.; Kwiecien, M.; Rosol, M.; Szczepaniec, A.; Buszkiewicz, P.; Banka, L. Method of producing new esters of α,ω-alkene diamino-N,N′-bis(1-aryl methyl phosponium) acids. Poland PL195533 B1, 28 September 2007. [Google Scholar]
- Liu, H.; Xu, K.; Ai, H.; Zhang, L.; Chen, M. Preparation and characterization of phosphorus-containing Mannich-type bases as curing agents for epoxy resin. Polym. Adv. Technol. 2009, 20, 753–758. [Google Scholar] [CrossRef]
- Villieras, J.; Rambaud, M. Ethyl α-(Hydroxymethyl)acrylate [2-propenoic acid, 2-(hydroxymethyl)-,ethyl ester]. Org. Synth. Coll. 1988, 66, 220. [Google Scholar] [CrossRef]
Entry | Compound | R | n | Yield (%) [b] | |
---|---|---|---|---|---|
Method A | Method B | ||||
1 | 4a | C6H5 | 2 | 55 | 60 |
2 | 4b | p-MeC6H4 | 2 | 71 | 57 |
3 | 4c | C6H5 | 3 | 69 | 74 |
4 | 4d | p-MeC6H4 | 3 | 87 | 79 |
5 | 4e | p-MeOC6H4 | 3 | 66 | 63 |
6 | 4f | p-ClC6H4 | 3 | 68 | 71 |
7 | 4g | p-FC6H4 | 3 | 60 | 58 |
8 | 4h | Me | 3 | 79 | 86 |
Entry | Compound | R | n | Yield (%) [a] |
---|---|---|---|---|
1 | 6a | C6H5 | 2 | 69 |
2 | 6b | p-MeC6H4 | 2 | 85 |
3 | 6c | C6H5 | 3 | 74 |
4 | 6d | p-MeC6H4 | 3 | 71 |
5 | 6e | p-MeOC6H4 | 3 | 74 |
6 | 6f | p-ClC6H4 | 3 | 87 |
7 | 6g | p-FC6H4 | 3 | 75 |
8 | 6h | Me | 3 | 69 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Souii, I.; Sanhoury, M.A.; Vicario, J.; Jiménez-Aberásturi, X.; Efrit, M.L.; M’rabet, H.; de los Santos, J.M. Synthesis and Characterization of a New Series of Bis(allylic-α-aminophosphonates) under Mild Reaction Conditions. Molecules 2023, 28, 4678. https://doi.org/10.3390/molecules28124678
Souii I, Sanhoury MA, Vicario J, Jiménez-Aberásturi X, Efrit ML, M’rabet H, de los Santos JM. Synthesis and Characterization of a New Series of Bis(allylic-α-aminophosphonates) under Mild Reaction Conditions. Molecules. 2023; 28(12):4678. https://doi.org/10.3390/molecules28124678
Chicago/Turabian StyleSouii, Ichrak, Med Abderrahmane Sanhoury, Javier Vicario, Xabier Jiménez-Aberásturi, Mohamed L. Efrit, Hedi M’rabet, and Jesús M. de los Santos. 2023. "Synthesis and Characterization of a New Series of Bis(allylic-α-aminophosphonates) under Mild Reaction Conditions" Molecules 28, no. 12: 4678. https://doi.org/10.3390/molecules28124678
APA StyleSouii, I., Sanhoury, M. A., Vicario, J., Jiménez-Aberásturi, X., Efrit, M. L., M’rabet, H., & de los Santos, J. M. (2023). Synthesis and Characterization of a New Series of Bis(allylic-α-aminophosphonates) under Mild Reaction Conditions. Molecules, 28(12), 4678. https://doi.org/10.3390/molecules28124678